Loading...
OTCM
EBRCZ
Market cap79mUSD
Oct 15, Last price  
0.11USD
Name

EBR Systems Inc

Chart & performance

D1W1MN
OTCM:EBRCZ chart
P/E
—
P/S
53.46
EPS
—
Vol. 1Y
—
Shs. 5Y
99.64%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
2m
1,293,935000001,617,000
Net income
-49m
L+141.68%
-24,812,7620-39,835,369-33,088,205-35,036,888-20,174,225-48,758,000
CFO
-53m
L+29.01%
000-30,355,918-32,697,514-41,229,820-53,192,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

EBR Systems, Inc. focuses on developing internal medical devices that utilize wireless technology for tissue stimulation. A key offering is their WiSE cardiac resynchronization therapy (CRT) system, which leverages proprietary cable-free technology to deliver electrical pacing directly into the heart's left ventricle. This innovative approach aims to address and eliminate the typical difficulties associated with traditional wired leads, such as challenging insertion, unintended nerve activation, device displacement, complex removal procedures, and the need for frequent repositioning. The company was established in 2003 and operates from its headquarters in Sunnyvale, California.

Key people

Executive Chairman of the Board · since 2019
John Mccutcheon
President, Chief Executive Officer, Executive Director · since 2019
Gary Doherty
Chief Financial Officer · since 2023
Michael Hendrickson
Chief Operating Officer · since 2021
Andrew Shute
Senior Vice President - Global Field Operations · since 2015
N. Parker Willis
Chief Technology Officer · since 2011
Pharoah Garma
Chief Regulatory Officer · since 2024
Spencer Kubo
Chief Medical Officer · since 2018
Kobe Li
Company Secretary, Australia · since 2025
Erik Strandberg
Chief Commercial Officer · since 2024
John Sellers
Company Secretary - Unites States · since 2021
Trevor Moody
Non-Executive Director · since 2017
Christopher Nave
Non-Executive Director · since 2017
Karen Drexler
Non-Executive Independent Director · since 2021
Bronwyn Evans
Non-Executive Independent Director · since 2021
David Steinhaus
Non-Executive Independent Director · since 2021
IPO date
Nov 24, 2021
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT